C011 Face Off: Evidence-Based Debates on Today’s Hottest Injectable Controversies
DESCRIPTION
This course explores major controversies in aesthetic dermatology through expert-led pro and con debates on surgery versus injectables, the role of GLP-1 receptor agonists and hormones in dermatologic practice, management of treatment-related skin and aesthetic changes, infraorbital rejuvenation, and the use of radiofrequency microneedling, injectables, and ultrasound-guided techniques. Emphasizing evidence-based analysis, patient selection, safety, and outcomes, the course will enable participants to critically evaluate differing perspectives and apply balanced, individualized approaches to complex aesthetic concerns.
LEARNING OBJECTIVES
Critically appraise controversies in aesthetic dermatology, including the relative roles of surgery, injectables, energy-based devices, and ultrasound-assisted approaches in facial rejuvenation and contouring.
Evaluate the role of GLP-1 receptor agonists and hormone therapies in derm practice, including indications, safety, scope of practice issues, and recognition, timing, and management of skin & aesthetic changes.
Integrate evidence-based strategies for complex cosmetic concerns, including infraorbital rejuvenation, volume changes, and combination therapy planning, to optimize outcomes and minimize complications.
SCHEDULE
1:00 PM
Introduction
Vince Bertucci, MD, FAAD, Melanie Palm, MD, FAAD
1:02 PM
Facial Surgery and Injectables: Friends or Foes? (PRO)
Jennifer Salsberg, MD, FAAD
1:12 PM
Facial Surgery and Injectables: Friends or Foes? (CON)
Shawn B. Allen, MD, FAAD
1:22 PM
Facial Surgery and Injectables: Friends or Foes? (Q&A)
1:30 PM
GLP-1 Receptor Agonists & Hormones: Should Derms Prescribe Them? (PRO)
Kristine A. Romine, MD, FAAD
1:40 PM
GLP-1 Receptor Agonists & Hormones: Should Derms prescribe them? (CON)
Neal D. Bhatia, MD, FAAD
1:50 PM
GLP-1 Receptor Agonists & Hormones: Should Derms prescribe them? (Q&A)
2:00 PM
GLP-1 Receptor Agonists: Managing their Effects (PRO)
Jody A. Comstock, MD, FAAD
2:10 PM
GLP-1 Receptor Agonists: Managing their Effects (CON)
Jennifer M. Rullan, MD, FAAD
2:20 PM
GLP-1 Receptor Agonists: Managing their Effects (Q&A)
2:30 PM
The Infraorbital Dilemma: Fillers vs. Surgery (PRO)
Rebecca A. Kazin, MD, FAAD
2:40 PM
The Infraorbital Dilemma: Fillers vs. Surgery (CON)
Bobby Korn, MD, PhD
2:50 PM
The Infraorbital Dilemma: Fillers vs. Surgery (Q&A)
3:00 PM
Radiofrequency Microneedling & Injectables: Where do we Stand? (PRO)
Rishi Chopra, MS, MD, FAAD
3:10 PM
Radiofrequency Microneedling & Injectables: Where do we Stand? (CON)
Hassan I. Galadari, MD, FAAD
3:20 PM
Radiofrequency Microneedling & Injectables: Where do we Stand? (Q&A)
3:30 PM
Ultrasound-Assisted Injectables: Helpful or Hindrance? (PRO)
Ardalan Minokadeh, MD, PhD, FAAD
3:40 PM
Ultrasound-Assisted Injectables: Helpful or Hindrance? (CON)
Rohit Kakar, MD, FAAD
3:50 PM
Ultrasound-Assisted Injectables: Helpful or Hindrance? (Q&A)
DIRECTOR
Vince Bertucci, MD, FAAD
Division of Dermatology, University of Toronto, Toronto, Canada
CO-DIRECTOR
Melanie Palm, MD, FAAD
SPEAKERS
Shawn B. Allen, MD, FAAD
Neal D. Bhatia, MD, FAAD
Therapeutics Clinical Research, San Diego, California
Rishi Chopra, MS, MD, FAAD
Jody A. Comstock, MD, FAAD
Hassan I. Galadari, MD, FAAD
Rohit Kakar, MD, FAAD
Rebecca A. Kazin, MD, FAAD
Bobby Korn, MD, PhD
Marina Landau, MD, IFAAD
Ardalan Minokadeh, MD, PhD, FAAD
Cosmetic Dermatologist / Skin Care and Laser Physicians of Beverly Hills
Kristine A. Romine, MD, FAAD
BelleSante by Kristine Romine, MD
Jennifer M. Rullan, MD, FAAD
Dermatology Institute
Jennifer Salsberg, MD, FAAD
AvenueMD
HANDOUTS
DISCLOSURES
Shawn B. Allen, MD, FAAD
Galderma – Speaker(Honoraria);
Vince Bertucci, MD, FAAD
Allergan, Inc – Consultant (1099 relationship)(Fees); Allergan, Inc. – Advisory Board(Fees), Investigator(Fees), Speaker(Honoraria); AMNI Aesthetic Medicine Network Inc. – Consultant(Honoraria); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Clarion Medical Technologies – Speaker(Honoraria); Evolus, Inc. – Advisory Board(Fees), Speaker(Honoraria); Galderma Canada, Inc – Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Fees); Galderma USA – Investigator(Fees); Hydrafacial – Advisory Board(Fees); L'Oreal – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Medscape – Speaker/Faculty Education(Fees); Revance Therapeutics, Inc. – Advisory Board(Fees);
Neal D. Bhatia, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria), Investigator(Grants/Research Funding); Alumis – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); Biofrontera AG – Consultant(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); Castle Biosciences – Consultant(Honoraria); Celldex – Investigator(Grants/Research Funding); Dermeleve – Consultant (1099 relationship)(Honoraria); Eli Lilly – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Consultant(Honoraria); Johnson and Johnson Consumer Products Company – Investigator(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Consultant(Honoraria); LEO Pharma, US – Investigator(Grants/Research Funding); Novartis – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Practical Dermatology – Other(Honoraria); Sagimet Biosciences – Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Soligenix, Inc – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); VeraDermics Inc. – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);
Rishi Chopra, MS, MD, FAAD
Accure, Inc – Consultant(Fees); Cutera, Inc. – Speaker(Honoraria); Cynosure – Consultant (1099 relationship)(Equipment); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Evolus, Inc. – Speaker(Honoraria); Sofwave – Speaker(Honoraria);
Jody A. Comstock, MD, FAAD
Nutrafol – Consultant (1099 relationship)(Honoraria); Revance – Speaker/Faculty Education(Honoraria); SkinBetter Science – Consultant(Honoraria); Sofwave – Consultant (1099 relationship)(Honoraria); Solta Medical – Consultant (1099 relationship)(Honoraria);
Hassan I. Galadari, MD, FAAD
No financial relationships exist with ineligible companies.
Rohit Kakar, MD, FAAD
Allergan Aesthetics – Advisory Board(Honoraria); Galderma – Consultant (1099 relationship)(Honoraria); Merz Aesthetics – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Consultant (1099 relationship)(Honoraria); Veradermics – Advisory Board(Honoraria);
Rebecca A. Kazin, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding), Stockholder(Stock); Galderma USA – Investigator(Grants/Research Funding), Speaker(Honoraria); Novaestiq Corp – Stockholder Private Company(Stock);
Bobby Korn, MD, PhD
Amgen – Consultant (1099 relationship)(Honoraria); argenx – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Genentech – Consultant (1099 relationship)(Honoraria);
Marina Landau, MD, IFAAD
No financial relationships exist with ineligible companies.
Ardalan Minokadeh, MD, PhD, FAAD
Allergan Aesthetics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Evolus, Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Galderma – Investigator(Grants/Research Funding); Merz Aesthetics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); symatese – Investigator(Grants/Research Funding); VeraDermics Inc. – Advisory Board(Honoraria);
Melanie Palm, MD, FAAD
Alastin Skincare, Inc – Investigator(Grants/Research Funding); Allergan, Inc – Advisory Board(Honoraria); BTL Industries – Speaker/Faculty Education(Honoraria); elta md – Advisory Board(Fees); Galderma Laboratories, L.P. – Consultant(Honoraria); L'Oreal USA Inc. – Investigator(Honoraria); Lumenis – Speaker(Honoraria); Merz Aesthetics – Speaker/Faculty Education(Honoraria); Revision Skincare – Investigator(Grants/Research Funding);
Kristine A. Romine, MD, FAAD
No financial relationships exist with ineligible companies.
Jennifer M. Rullan, MD, FAAD
No financial relationships exist with ineligible companies.
Jennifer Salsberg, MD, FAAD
Galderma – Advisory Board(Honoraria), Speaker(Honoraria); L'Oreal – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); ZO Skin Health – Speaker(Honoraria);